Profile
Sapan Shah currently works at Glyscend, Inc., as Chief Executive Officer & Director from 2023.
Dr. Shah also formerly worked at Rycarma Therapeutics, Inc., as Chief Executive Officer, Shionogi, Inc., as Chief Executive Officer, and StrideBio, Inc., as Chief Executive Officer.
Dr. Shah received his undergraduate degree from Northwestern University and doctorate degree from Yale University.
Sapan Shah active positions
| Companies | Position | Start |
|---|---|---|
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Chief Executive Officer | 2023-09-04 |
Former positions of Sapan Shah
| Companies | Position | End |
|---|---|---|
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Chief Executive Officer | - |
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Chief Executive Officer | - |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Chief Executive Officer | - |
Training of Sapan Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Health Technology |
- Stock Market
- Insiders
- Sapan Shah
















